Pharmacokinetics - Open Access .click

Results 1 to 10 of about 232,239 (120)

The pharmacokinetics of amygdalin [PDF]

Archives of Toxicology, 1982
Amygdalin (D-mandelonitrile-beta-D-gentiobioside) is a cyanogenic glycoside claimed to show anti-cancer activity, sold under the incorrect name "Laetrile". For a sensible discussion of its alleged activity and its established toxicity it is necessary that its fate in the organism is known. The pharmacokinetics of amygdalin have been investigated in the
Rauws, AG, Olling, M, Timmerman, A
openaire +3 more sources

Pharmacokinetics and population pharmacokinetics in pediatric oncology [PDF]

Pediatric Blood & Cancer, 2019
AbstractPharmacokinetic research has become increasingly important in pediatric oncology as it can have direct clinical implications and is a crucial component in individualized medicine. Population pharmacokinetics has become a popular method especially in children, due to the potential for sparse sampling, flexible sampling times, computing of ...
Sebastiaan D.T. Sassen +3 more
openaire +3 more sources

Fractal Pharmacokinetics [PDF]

Computational and Mathematical Methods in Medicine, 2009
Pharmacokinetics (PK) has been traditionally dealt with under the homogeneity assumption. However, biological systems are nowadays comprehensively understood as being inherently fractal. Specifically, the microenvironments where drug molecules interact with membrane interfaces, metabolic enzymes or pharmacological receptors, are unanimously recognized ...
openaire +2 more sources

Pharmacokinetics of cefotaxime [PDF]

Antimicrobial Agents and Chemotherapy, 1979
The pharmacokinetics of cefotaxime after intramuscular injection and intravenous infusion were determined. The mean peak serum level after the 500-mg intramuscular dose was 11.7 micrograms/ml, and it was 20.5 micrograms/ml after a 1,000-mg dose. The serum half-life was 1.2 and 1.3 h, respectively for the two doses.
K P, Fu +4 more
openaire +2 more sources

Pharmacokinetics as a Biomarker

Clinical and Translational Science
ABSTRACT Pharmacokinetics (PK) has long been differentiated from pharmacodynamics (PD) and biomarkers, yet this distinction undervalues PK's translational relevance. In this Perspective, we propose that PK itself functions as a biomarker that bridges dose, exposure, and response.
John A. Wagner, Sonal Singh, Zachary L. Taylor +2 more
openaire +3 more sources

Pharmacokinetics [PDF]